Natural Product: NPC201055| Natural Product ID | NPC201055 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| Naloxone |
| IUPAC Name | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one |
| Synonyms | Nalone; Naloxone; Narcan; Narcanti; Suboxone |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | CHEMBL80 |
| PubChem CID |
5284596 |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | UZHSEJADLWPNLE-GRGSLBFTSA-N |
| Standard InCHI | InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 |
| SMILES | C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O |
  Calculated Properties| Molecular Weight:   | 327.15 | Volume:   | 327.373 Van der Waals volume.
|
| Dense:   | 0.999 | LogP:   | 1.276 The logarithm of the n-octanol/water distribution coefficients.
|
| logD7.4:   | 1.512 The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
|
LogS:   | -3.024 The logarithm of aqueous solubility value.
|
| Rotatable Bonds:   | 2.0 | Rigid Bonds:   | 24.0 |
| TPSA:   | 70.0 Topological Polar Surface Area.
|
H-Bond Acceptor:   | 5.0 |
| H-Bond Donor:   | 2.0 | Rings:   | 5.0 |
| Heavy Atoms:   | 5.0 |
| QED Drug-Likeness Score:   | 0.802 | GASA:   | 1.0 GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
|
| Synthetic Accessibility Score:   | 5.178 | Fsp3:   | 0.526 |
| MCE-18:   | 134.0 MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
|
Lipinski Rule-of-5:   | Rejected |
| Pfizer Rule:   | Rejected | GSK Rule:   | Rejected |
| Golden Triangle Rule:   | Rejected | BMS Rule:   | 0 |
| Chelating Alert:   | 1 | PAINS Alert:   | 0 |
| Colloidal aggregators:   | 0.027 | Fluc inhibitor:   | 0.003 The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
|
| Blue fluorescence:   | 0.132 The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
|
Green fluorescence:   | 0.268 The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
|
| Reactive compounds:   | 0.004 | Promiscuous compounds:   | 0.125 |
| Caco-2 Permeability:   | -4.675 | MDCK Permeability:   | -4.619 |
| Pgp-inhibitor:   | 0.0 | Pgp-substrate:   | 0.196 |
| PAMPA:   |
0.068 The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
|
Human Intestinal Absorption (HIA):   | 0.0 |
| 20% Bioavailability (F20%):   | 0.178 | 30% Bioavailability (F30%):   | 0.903 |
| 50% Bioavailability (F50%):   | 0.997 |
| Blood-Brain-Barrier Penetration (BBB):   | 1.0 | MRP1:   | 0.963 |
| Plasma Protein Binding (PPB):   | 65.571% | Volume Distribution (VD):   | 0.225 |
| Fu: |
33.201% The fraction unbound in plasms.
|
OATP1B1 inhibitor:   | 0.992 |
| OATP1B3 inhibitor:   | 0.908 | BCRP inhibitor:   | 0.03 |
| BSEP inhibitor:   | 0.001 |
| CYP1A2-inhibitor:   | 1.0 | CYP1A2-substrate:   | 0.0 |
| CYP2C19-inhibitor:   | 0.144 | CYP2C19-substrate:   | 0.0 |
| CYP2C9-inhibitor:   | 0.798 | CYP2C9-substrate:   | 0.043 |
| CYP2D6-inhibitor:   | 1.0 | CYP2D6-substrate:   | 0.0 |
| CYP3A4-inhibitor:   | 1.0 | CYP3A4-substrate:   | 0.204 |
| CYP2B6-substrate:   | 0.0 | CYP2C8-inhibitor:   | 0.004 |
| HLM stability:   |
0.001 Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.
|
| Clearance (CL):   | 20.095 | Half-life (T1/2):   | 3.351 |
| hERG Blockers:   | 0.082 | hERG Blockers (10um):   | 0.385 |
| Human Hepatotoxicity (H-HT):   | 0.648 | Drug-induced Liver Injury (DILI):   | 0.035 |
| AMES Toxicity:   | 0.548 | Rat Oral Acute Toxicity:   | 0.691 |
| Maximum Recommended Daily Dose:   | 0.692 | Skin Sensitization:   | 0.889 |
| Carcinogencity:   | 0.636 | Eye Corrosion:   | 0.007 |
| Eye Irritation:   | 0.771 | Respiratory Toxicity:   | 0.78 |
| Drug-induced Neurotoxicity:   | 0.338 | Ototoxicity:   | 0.474 |
| Hematotoxicity:   | 0.199 | Drug-induced Nephrotoxicity:   | 0.225 |
| Genotoxicity:   | 0.789 | RPMI-8226 Immunitoxicity:   | 0.046 |
| A549 Cytotoxicity:   | 0.073 | Hek293 Cytotoxicity:   | 0.33 |
| BCF:   |
0.454 Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
|
IGC50:   |
3.1 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
|
| LC50DM:   |
4.803 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
|
LC50FM:   |
3.892 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].
|
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | DOI[10.1042/BA20020118] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | DOI[10.1556/abot.45.2003.3-4.15] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15019787] |
| NPO40838 | Elaeocarpus habbemensis | Species | Elaeocarpaceae | Eukaryota | Leaves | n.a. | n.a. |
PMID[17388627] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22029392] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23517479] |
| NPO41029 | Perovskia atriplicifolia | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26035635] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[37685099] |
| NPO41029 | Perovskia atriplicifolia | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | Latex Exudate | n.a. | n.a. | Database[FooDB] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
| NPO9498 | Papaver somniferum | Species | Papaveraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 1.07 | nM | PMID[2563773] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 10.7 | nM | PMID[12747782] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 3.63 | nM | PMID[12747782] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 37.0 | nM | PMID[12747782] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | IC50 | = | 49.8 | nM | PMID[12747782] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Max inhibition | = | 98.0 | % | PMID[12747782] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Max stimulation | = | 30.0 | % | PMID[12747782] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | EC50 | = | 6.6 | nM | PMID[12747782] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 2.0 | nM | PMID[11585443] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | IC50 | = | 1.5 | nM | PMID[11585443] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 151.0 | nM | PMID[11585443] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 3.7 | nM | PMID[8057274] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 66.0 | nM | PMID[8057274] |
| NPT1168 | Individual protein | Mu opioid receptor | Mus musculus | AD50 | = | 0.08 | mg kg-1 | PMID[8410999] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Kd | = | 0.4 | nM | PMID[3007760] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Kd | = | 5.0 | nM | PMID[3007760] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Ki | = | 1.1 | nM | PMID[7932535] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 12.0 | nM | PMID[7932535] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 19.0 | nM | PMID[7932535] |
| NPT296 | Individual protein | Sigma opioid receptor | Homo sapiens | Ki | > | 100000.0 | nM | PMID[7932535] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 3.2 | nM | PMID[11495592] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Ki | = | 0.68 | nM | PMID[17420073] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 6.3 | nM | PMID[8410999] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | IC50 | = | 8.9 | nM | PMID[1320121] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | IC50 | = | 50.0 | nM | PMID[1320121] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 62.0 | nM | PMID[1320121] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 1.4 | nM | PMID[10741545] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 41.0 | nM | PMID[10741545] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 1.2 | nM | PMID[19027293] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Kt | = | 260000000.0 | n.a. | PMID[2999404] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | ln Kt | = | 19.4 | n.a. | PMID[2999404] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | ln Kp | = | 20.7 | n.a. | PMID[2999404] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 3.7 | nM | PMID[18313920] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 9.2 | nM | PMID[18313920] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 33.0 | nM | PMID[18313920] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 7.3 | nM | PMID[18313920] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Kd | = | 3.0 | nM | PMID[10782696] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Kd | = | 1.862 | nM | PMID[11133082] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Activity | = | 62.0 | n.a. | PMID[7515442] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Activity | = | 51.0 | n.a. | PMID[7515442] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Kd | = | 3.162 | nM | PMID[8057274] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Kd | = | 19.95 | nM | PMID[8057274] |
| NPT1167 | Individual protein | Delta opioid receptor | Mus musculus | Kd | = | 50.12 | nM | PMID[8057274] |
| NPT3056 | Individual protein | Dopamine D3 receptor | Rattus norvegicus | Ki | > | 20000.0 | nM | PMID[8098771] |
| NPT296 | Individual protein | Sigma opioid receptor | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[1469697] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | KT | = | 19.4 | n.a. | PMID[2831361] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Control | = | 111.0 | % | PMID[2167979] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Control | = | 105.0 | % | PMID[2167979] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | % recovery | = | 0.0 | n.a. | PMID[1320121] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | % recovery | = | 100.0 | n.a. | PMID[1320121] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | % recovery | = | 0.0 | n.a. | PMID[1320121] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | % recovery | = | 100.0 | n.a. | PMID[1320121] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Kd | = | 0.2188 | nM | PMID[18207400] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Activity | = | 0.1 | % | PMID[18207400] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.79 | nM | PMID[17407276] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 1.1 | nM | PMID[17407276] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 76.0 | nM | PMID[17407276] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Emax | = | 25.0 | % | PMID[17407276] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | EC50 | = | 10.0 | nM | PMID[17407276] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Imax | = | 55.0 | % | PMID[17407276] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | IC50 | = | 320.0 | nM | PMID[17407276] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Emax | = | 13.0 | % | PMID[17407276] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Imax | = | 92.0 | % | PMID[17407276] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 23.0 | nM | PMID[17407276] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 138.0 | nM | PMID[16989522] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 3.17 | nM | PMID[17420073] |
| NPT1168 | Individual protein | Mu opioid receptor | Mus musculus | Kd | = | 10.23 | nM | PMID[17962026] |
| NPT1167 | Individual protein | Delta opioid receptor | Mus musculus | Kd | = | 44.67 | nM | PMID[17962026] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.66 | nM | PMID[19027293] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 120.0 | nM | PMID[19027293] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 1.6 | nM | PMID[8496700] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 42.6 | nM | PMID[8496700] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Activity | = | 90.0 | % | PMID[8496700] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Activity | = | 80.0 | % | PMID[8496700] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Activity | = | 50.0 | % | PMID[19836950] |
| NPT216 | Individual protein | Adenosine A1 receptor | Homo sapiens | Ki | > | 50000.0 | nM | PMID[19836950] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 1.5 | nM | PMID[19836950] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 3.0 | nM | PMID[20055417] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.98 | nM | PMID[20055417] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 51.0 | nM | PMID[20055417] |
| NPT1067 | Individual protein | Sigma opioid receptor | Rattus norvegicus | Ki | > | 10000.0 | nM | PMID[20055417] |
| NPT1167 | Individual protein | Delta opioid receptor | Mus musculus | Activity | = | 101.0 | % | PMID[19646882] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Activity | = | 103.3 | % | PMID[19646882] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 14.7 | nM | PMID[20441176] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 7.3 | nM | PMID[25062506] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 38.0 | nM | PMID[21482470] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 0.25 | nM | PMID[21482470] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.23 | nM | PMID[21482470] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | pKb | = | 7.32 | n.a. | PMID[19527931] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | pKb | = | 9.09 | n.a. | PMID[19527931] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 4.467 | nM | PMID[19527931] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 21.38 | nM | PMID[19527931] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.5623 | nM | PMID[19527931] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | pKb | = | 7.14 | n.a. | PMID[19527931] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 4.23 | nM | PMID[21621410] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 2.27 | nM | PMID[21621410] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 0.57 | nM | PMID[21621410] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Activity | = | 106.4 | % | PMID[26035635] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Activity | = | 101.6 | % | PMID[26035635] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Activity | = | 97.0 | % | PMID[26035635] |
| NPT110 | Individual protein | Cytochrome P450 2D6 | Homo sapiens | IC50 | = | 2000.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 1461.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 515.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | IC50 | = | 75.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 30.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 20.0 | nM | DrugMatrix in vitro pharmacology data |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 8.063 | nM | DrugMatrix in vitro pharmacology data |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Inhibition | = | 100.1 | % | PMID[23659286] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Inhibition | = | 105.6 | % | PMID[23659286] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Inhibition | = | 103.4 | % | PMID[23659286] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 1.87 | nM | PMID[24171469] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Ki | = | 2.0 | nM | PMID[25087049] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 15.0 | nM | PMID[25062506] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 2.3 | nM | DOI[10.1039/C5MD00414D] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 103.0 | nM | DOI[10.1039/C5MD00414D] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 6.9 | nM | PMID[26411794] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 354.0 | nM | PMID[25268943] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 1516.0 | nM | PMID[25268943] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 362.0 | nM | PMID[25268943] |
| NPT1463 | Individual protein | Cytochrome P450 2J2 | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[23033255] |
| NPT2742 | Individual protein | Aldehyde oxidase | Homo sapiens | Fm | = | 0.07 | n.a. | PMID[22522748] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 30.0 | nM | PMID[26035635] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Ki | = | 2.1 | nM | PMID[26411794] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 1.148 | nM | PMID[26632862] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 1.259 | nM | PMID[26632862] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 3.1 | nM | DOI[10.1039/C5MD00414D] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 15.0 | nM | DOI[10.1039/C5MD00414D] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Ki | = | 2.3 | nM | PMID[30543421] |
| NPT1249 | Individual protein | Canalicular multispecific organic anion transporter 2 | Homo sapiens | IC50 | > | 133000.0 | nM | PMID[23956101] |
| NPT1028 | Individual protein | Multidrug resistance-associated protein 4 | Homo sapiens | IC50 | > | 133000.0 | nM | PMID[23956101] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Inhibition | = | 50.0 | % | PMID[28726402] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 45.0 | nM | PMID[28726402] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 94.84 | nM | PMID[28726402] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Inhibition | = | 95.0 | % | PMID[29649744] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Inhibition | = | 81.0 | % | PMID[29649744] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Inhibition | = | 93.0 | % | PMID[29649744] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Inhibition | = | 83.0 | % | PMID[29649744] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Inhibition | = | 94.0 | % | PMID[29649744] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Inhibition | = | 92.0 | % | PMID[29649744] |
| NPT1168 | Individual protein | Mu opioid receptor | Mus musculus | IC50 | = | 15.37 | nM | PMID[31782922] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Emax | = | 99.0 | % | PMID[31220675] |
| NPT1069 | Individual protein | Mu opioid receptor | Rattus norvegicus | Emax | = | 98.0 | % | PMID[31220675] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 78.2 | nM | PMID[31834798] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 72.8 | nM | PMID[31834798] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 51.0 | nM | PMID[31834798] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 51.2 | nM | PMID[30996778] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 70.0 | nM | PMID[30996778] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 146.0 | nM | PMID[30996778] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 43.0 | nM | PMID[32435376] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 59.5 | nM | PMID[32530286] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 98.1 | nM | PMID[32530286] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | IC50 | = | 153.0 | nM | PMID[32530286] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | IC50 | = | 140.0 | nM | PMID[27797517] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | = | 15.85 | nM | PMID[32870011] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Ki | = | 1.0 | nM | PMID[32870011] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | Ki | = | 15.85 | nM | PMID[32870011] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 27.0 | nM | PMID[35308026] |
| NPT1074 | Individual protein | Mu opioid receptor | Cavia porcellus | Ki | = | 2.3 | nM | PMID[35033825] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[37437224] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 722.0 | nM | PMID[37437224] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | IC50 | = | 302.0 | nM | PMID[34011153] |
| NPT1075 | Individual protein | Kappa opioid receptor | Cavia porcellus | Ki | = | 7.3 | nM | PMID[35033825] |
| NPT3601 | Individual protein | Kappa opioid receptor | Rattus norvegicus | AD50 | = | 3.5 | mg kg-1 | PMID[8410999] |
| NPT3601 | Individual protein | Kappa opioid receptor | Rattus norvegicus | Kd | = | 1.0 | nM | PMID[3007760] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | IC50 | = | 43.0 | nM | PMID[1320121] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Control | = | 0.0 | % | PMID[2153826] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Control | = | 98.0 | % | PMID[2153826] |
| NPT3601 | Individual protein | Kappa opioid receptor | Rattus norvegicus | Kd | = | 4.5 | nM | PMID[10782696] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Recovery | = | 0.0 | % | PMID[1652019] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Recovery | = | 100.0 | % | PMID[1652019] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Control | = | 72.0 | % | PMID[6248645] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Control | = | 89.0 | % | PMID[6248645] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | Ratio | = | 1.0 | n.a. | PMID[2536439] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | % recovery | = | 0.0 | n.a. | PMID[1320121] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | % recovery | = | 100.0 | n.a. | PMID[1320121] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | IC50 | = | 1.6 | nM | PMID[16250647] |
| NPT695 | Individual protein | UDP-glucuronosyltransferase 1-8 | Homo sapiens | Activity | = | 81.0 | pm/min/mg | PMID[10836148] |
| NPT4389 | Protein family | Opioid receptors; mu/kappa/delta | Homo sapiens | IC50 | = | 5.5 | nM | PMID[197237] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | IC50 | > | 135000.0 | nM | PMID[20829430] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | IC50 | = | 549000.0 | nM | PMID[22961681] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | IC50 | > | 133000.0 | nM | PMID[23956101] |
| NPT29005 | Single protein | Metastin receptor | Homo sapiens | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT29770 | Single protein | Prolactin-releasing peptide | Homo sapiens | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Kd | = | 18.0 | nM | PMID[3007760] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Ki | = | 32.0 | nM | PMID[8410999] |
| NPT5132 | Individual protein | C-C chemokine receptor type 5 | Mus musculus | Kd | = | 10.5 | nM | PMID[17389363] |
| NPT5132 | Individual protein | C-C chemokine receptor type 5 | Mus musculus | Kd | = | 20.8 | nM | PMID[17389363] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Activity | = | 23.0 | % | PMID[19640720] |
| NPT697 | Individual protein | UDP-glucuronosyltransferase 2B7 | Homo sapiens | Activity | = | 2908.0 | pm/min/mg | PMID[10836148] |
| NPT697 | Individual protein | UDP-glucuronosyltransferase 2B7 | Homo sapiens | Activity | = | 3462.0 | pm/min/mg | PMID[10836148] |
| NPT697 | Individual protein | UDP-glucuronosyltransferase 2B7 | Homo sapiens | Activity | = | 131.0 | pm/min/mg | PMID[10836148] |
| NPT697 | Individual protein | UDP-glucuronosyltransferase 2B7 | Homo sapiens | Activity | = | 3400.0 | pm/min/mg | PMID[10836148] |
| NPT317 | Nucleic acid | Nucleic Acid | n.a. | Ratio | = | 1.0 | n.a. | PMID[22275465] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Ki | = | 2.5 | nM | PMID[26411794] |
| NPT612 | Individual protein | Canalicular multispecific organic anion transporter 1 | Homo sapiens | IC50 | > | 133000.0 | nM | PMID[23956101] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Ki | = | 2.4 | nM | DOI[10.1039/C6MD00441E] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Ki | = | 103.0 | nM | PMID[30543421] |
| NPT5971 | Individual protein | Nociceptin receptor | Homo sapiens | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT3600 | Individual protein | Delta opioid receptor | Rattus norvegicus | Ki | = | 103.0 | nM | PMID[35033825] |
| NPT28781 | Single protein | Cytochrome b-245 heavy chain | Homo sapiens | IC50 | = | 1960.0 | nM | PMID[37650225] |
| NPT2863 | Protein family | Opioid receptor | Mus musculus | IC50 | = | 500000.0 | nM | PMID[2785211] |
| NPT3603 | Individual protein | Kappa opioid receptor | Mus musculus | AD50 | = | 1.1 | mg kg-1 | PMID[8410999] |
| NPT2863 | Protein family | Opioid receptor | Mus musculus | Control | = | 25.0 | % | PMID[6209395] |
| NPT2863 | Protein family | Opioid receptor | Mus musculus | Control | = | 105.0 | % | PMID[6209395] |
| NPT2863 | Protein family | Opioid receptor | Mus musculus | Control | = | 15.0 | % | PMID[6209395] |
| NPT2863 | Protein family | Opioid receptor | Mus musculus | Control | = | 108.0 | % | PMID[6209395] |
| NPT3603 | Individual protein | Kappa opioid receptor | Mus musculus | Kd | = | 125.89 | nM | PMID[17962026] |
| NPT901 | Individual protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 0.0 | pm/min/mg | PMID[10836148] |
| NPT902 | Individual protein | UDP-glucuronosyltransferase 1A4 | Homo sapiens | Activity | = | 0.0 | pm/min/mg | PMID[10836148] |
| NPT29454 | Single protein | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Homo sapiens | Inhibition | = | 9.526 | % | PMID[38318365] |
| NPT30048 | Single protein | Pyroglutamylated RFamide peptide receptor | Homo sapiens | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT29454 | Single protein | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Homo sapiens | Inhibition | = | -8.071 | % | PMID[38318365] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 3.0 | n.a. | PMID[3007760] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 3.2 | n.a. | PMID[3007760] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | Kd | = | 154.0 | nM | PMID[3007760] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | Ratio | = | 1.1 | n.a. | PMID[3007760] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 1.4 | nM | PMID[6600791] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 12.0 | nM | PMID[6600791] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 150.0 | nM | PMID[6276546] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 44.0 | nM | PMID[6276546] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | ED50 | = | 0.11 | umol.kg-1 | PMID[6796691] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 0.009 | nM | PMID[6094809] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 0.004 | nM | PMID[6094809] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | Ratio | = | 2.57 | n.a. | PMID[6094809] |
| NPT5130 | Individual protein | Mu opioid receptor | Bos taurus | Activity | = | 70.0 | n.a. | PMID[7515442] |
| NPT5130 | Individual protein | Mu opioid receptor | Bos taurus | IC50 | = | 5.0 | nM | PMID[2165166] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | IC50 | = | 2.0 | nM | PMID[2536439] |
| NPT699 | Individual protein | UDP-glucuronosyltransferase 1-10 | Homo sapiens | Activity | = | 0.0 | pm/min/mg | PMID[10836148] |
| NPT694 | Individual protein | UDP-glucuronosyltransferase 1-3 | Homo sapiens | Activity | = | 14.0 | pm/min/mg | PMID[10836148] |
| NPT704 | Individual protein | UDP-glucuronosyltransferase 2B15 | Homo sapiens | Activity | = | 0.0 | pm/min/mg | PMID[10836148] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | EC50 | = | 1.5 | nM | PMID[73588] |
| NPT3590 | Protein family | Opioid receptor | Rattus norvegicus | Kd | = | 1.0 | nM | PMID[206698] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT611 | Cell line | Hepatocyte | Homo sapiens | logCL | = | 1.29 | n.a. | PMID[18768239] |
| NPT616 | Cell line | MDCK | Canis lupus familiaris | Ratio | = | 0.7 | n.a. | PMID[21051535] |
| NPT1258 | Others | Opioid receptors; mu & delta | Homo sapiens | Selectivity ratio | = | 7.0 | n.a. | PMID[2157011] |
| NPT1258 | Others | Opioid receptors; mu & delta | Homo sapiens | Selectivity | = | 0.06 | n.a. | PMID[2828619] |
| NPT5131 | Others | Opioid receptors; delta & kappa | Homo sapiens | Selectivity | = | 0.4 | n.a. | PMID[2828619] |
| NPT5131 | Others | Opioid receptors; delta & kappa | Homo sapiens | Ratio Ki | = | 69.0 | n.a. | PMID[17407276] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT28438 | Unchecked | Unchecked | n.a. | Ki | = | 8.4 | nM | PMID[34008968] |
| NPT28438 | Unchecked | Unchecked | n.a. | Ki | n.a. | n.a. | n.a. | PMID[34008968] |
| NPT28438 | Unchecked | Unchecked | n.a. | Activity | n.a. | n.a. | n.a. | PMID[37437224] |
| NPT626 | Tissue | Liver microsome | Homo sapiens | Ratio | = | 28.0 | n.a. | PMID[22275465] |
| NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | = | 11.13 | % | DOI[10.6019/CHEMBL4296182] |
| NPT20 | Organism | Candida albicans | Candida albicans | Inhibition | = | -1.71 | % | DOI[10.6019/CHEMBL4296182] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Reversal | = | 30.0 | % | PMID[2563773] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Reversal | = | 100.0 | % | PMID[2563773] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Reversal | = | 50.0 | % | PMID[2563773] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Reversal | = | 0.0 | % | PMID[2563773] |
| NPT4390 | Others | Opioid receptors; mu & kappa | Homo sapiens | Selectivity ratio | = | 12.0 | n.a. | PMID[7636870] |
| NPT4390 | Others | Opioid receptors; mu & kappa | Homo sapiens | IC50 | = | 9.0 | nM | PMID[2536439] |
| NPT4390 | Others | Opioid receptors; mu & kappa | Homo sapiens | IC50 | = | 127.0 | nM | PMID[2536439] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Volume change | = | 23.0 | % | PMID[2536439] |
| NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | Rate change | = | 7.3 | % | PMID[2536439] |
| NPT4390 | Others | Opioid receptors; mu & kappa | Homo sapiens | Ratio Ki | = | 1.0 | n.a. | PMID[17407276] |
| NPT19 | Organism | Escherichia coli | Escherichia coli | Inhibition | = | 1.67 | % | DOI[10.6019/CHEMBL4296182] |
| NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | = | 6.26 | % | DOI[10.6019/CHEMBL4296182] |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 33491.5 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 26832.5 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Potency | n.a. | 21131.7 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 565.0 | n.a. | PMID[6276546] |
| NPT2 | Others | Unspecified | n.a. | Potency | = | 18.5 | n.a. | PMID[6330357] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.91 | n.a. | PMID[6325691] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 0.3 | n.a. | PMID[2999404] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 7460000.0 | nM | PMID[6319698] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 3.4 | n.a. | PMID[6312042] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 1.9 | n.a. | PMID[6312042] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 1.1 | n.a. | PMID[6312042] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 23.0 | nM | PMID[1652019] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 12.0 | n.a. | PMID[2536439] |
| NPT2 | Others | Unspecified | n.a. | Ratio | = | 7.0 | n.a. | PMID[2536439] |
| NPT2 | Others | Unspecified | n.a. | EC50 | = | 6.26 | nM | PMID[17962026] |
| NPT2 | Others | Unspecified | n.a. | EC50 | = | 9.1 | nM | PMID[17962026] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 25.0 | n.a. | PMID[18313920] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 9.0 | n.a. | PMID[18313920] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 0.55 | n.a. | PMID[19027293] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 100.0 | n.a. | PMID[19027293] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 1.8 | n.a. | PMID[20055417] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 49.0 | n.a. | PMID[20055417] |
| NPT2 | Others | Unspecified | n.a. | Ki | > | 10000.0 | nM | PMID[20055417] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 30.0 | nM | PMID[20575589] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 3.9 | nM | PMID[20575589] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 2.6 | nM | PMID[20575589] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 1.0 | n.a. | PMID[21482470] |
| NPT2 | Others | Unspecified | n.a. | Ratio Ki | = | 152.0 | n.a. | PMID[21482470] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 630000.0 | nM | PMID[15781124] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_bilirubinemia | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholecystitis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholelithiasis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cirrhosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic failure | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic necrosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatomegaly | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_jaundice | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver fatty | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver function tests abnormal | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_Combined Scores | = | 0.0 | n.a. | PMID[22194678] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 53.2 | nM | PMID[22734622] |
| NPT20913 | Tissue | Whole blood | Homo sapiens | Retention_time | = | 2.46 | min | DOI[10.1007/s00044-012-9977-1] |
| NPT2 | Others | Unspecified | n.a. | AC50 | n.a. | 44668.4 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | AC50 | n.a. | 39810.7 | nM | PubChem BioAssay data set |
| NPT2 | Others | Unspecified | n.a. | AC50 | n.a. | 25118.9 | nM | PubChem BioAssay data set |
| NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | = | -13.0 | % | DOI[10.6019/CHEMBL4296182] |
| NPT20632 | Organism | Chikungunya virus | Chikungunya virus | Activity | = | 121.5 | % | PMID[36940609] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver disease | = | 0.0 | n.a. | PMID[22194678] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT32 | Organism | Mus musculus | Mus musculus | Reversal type | = | 2.0 | n.a. | PMID[2563773] |
| NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.04 | mg kg-1 | PMID[11078198] |
| NPT32 | Organism | Mus musculus | Mus musculus | AD50 | = | 0.1 | n.a. | PMID[11078198] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.08 | umol.kg-1 | PMID[7205892] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | > | 100.0 | mg.kg-1 | PMID[73588] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.02 | mg.kg-1 | PMID[7932535] |
| NPT32 | Organism | Mus musculus | Mus musculus | Concentration | = | 10.05 | ng ml-1 | PMID[6276546] |
| NPT32 | Organism | Mus musculus | Mus musculus | Concentration | = | 0.51 | ng ml-1 | PMID[6276546] |
| NPT32 | Organism | Mus musculus | Mus musculus | Analgesia | = | 54.0 | % | PMID[6156240] |
| NPT32 | Organism | Mus musculus | Mus musculus | Kd | = | 2.951 | nM | PMID[6268787] |
| NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.03 | n.a. | PMID[3023611] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.06 | mg.kg-1 | PMID[6389867] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.05 | mg.kg-1 | PMID[8057274] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 1.5 | mg.kg-1 | PMID[8057274] |
| NPT32 | Organism | Mus musculus | Mus musculus | AD50 | = | 0.08 | mg kg-1 | PMID[8057274] |
| NPT32 | Organism | Mus musculus | Mus musculus | Analgesia | = | 32.0 | % | PMID[6248645] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.09 | mg.kg-1 | PMID[6248645] |
| NPT32 | Organism | Mus musculus | Mus musculus | Writhing number | = | 31.2 | n.a. | PMID[6298420] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.044 | mg.kg-1 | PMID[2536439] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 2.9 | mg.kg-1 | PMID[2536439] |
| NPT32 | Organism | Mus musculus | Mus musculus | Reduction | = | 87.0 | % | PMID[2536439] |
| NPT32 | Organism | Mus musculus | Mus musculus | Reduction | = | 83.0 | % | PMID[2536439] |
| NPT32 | Organism | Mus musculus | Mus musculus | AD50 | = | 2.38 | ng | PMID[17142049] |
| NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 15.1 | s | PMID[17276075] |
| NPT32 | Organism | Mus musculus | Mus musculus | MPE | = | 0.34 | % | PMID[18207400] |
| NPT32 | Organism | Mus musculus | Mus musculus | MPE | = | 0.22 | % | PMID[18207400] |
| NPT32 | Organism | Mus musculus | Mus musculus | MPE | = | 2.19 | % | PMID[18207400] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.03 | mg.kg-1 | PMID[17389363] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.014 | nmol | PMID[17389363] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.045 | nmol | PMID[17389363] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 2.83 | umol.kg-1 | PMID[17389363] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.03 | nmol | PMID[17389363] |
| NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.05 | mg kg-1 | PMID[24144240] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 0.14 | mg.kg-1 | PMID[73588] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 60.0 | mg.kg-1 | PMID[31481] |
| NPT32 | Organism | Mus musculus | Mus musculus | ED50 | = | 103.0 | mg.kg-1 | PMID[31481] |
| NPT32 | Organism | Mus musculus | Mus musculus | Activity | n.a. | n.a. | n.a. | PMID[36538027] |
| NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Clearance | = | 32.1 | ul min-1 | PMID[10602692] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | Clearance | = | 16.7 | ul min-1 | PMID[10602692] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 0.91 | % | PMID[20022146] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | Fabs | = | 91.0 | % | PMID[21051535] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AD50 | = | 0.023 | mg kg-1 | PMID[6276546] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AD99 | = | 0.1 | mg kg-1 | PMID[6276546] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Duration | = | 3.0 | hr | PMID[6276546] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AD50 | = | 13.0 | mg kg-1 | PMID[6276546] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Kd | = | 10.0 | nM | PMID[2158564] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 1.2 | mg.kg-1 | PMID[8410999] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 6.39 | nM | PMID[6330357] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Binding activity | = | 2625.0 | c.p.m. | PMID[6156240] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ki | > | 6000.0 | nM | PMID[1825848] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 46.0 | nM | PMID[6325691] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 42.0 | nM | PMID[6325691] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.11 | umol.kg-1 | PMID[7192744] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ki | > | 10000.0 | nM | PMID[8093734] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Clearance | = | 54.6 | ul min-1 | PMID[10602692] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_elevated liver function tests | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatitis | = | 0.0 | n.a. | PMID[22194678] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | > | 100.0 | mg.kg-1 | PMID[73588] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 0.051 | mg.kg-1 | PMID[73588] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AD50 | = | 0.008 | mg kg-1 | PMID[31481] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AD50 | = | 0.004 | mg kg-1 | PMID[41949] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 52.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 42000.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 368.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 96.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 163.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 26670000.0 | nM | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 103.67 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 706.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 678.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 2.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1783.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 116.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 9.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 126.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 6.32 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 144.23 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 2.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 59000.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 18.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BASO | = | 0.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 394.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 14212.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 229.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1597.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BASOLE | = | 0.0 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 2.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5290000.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 33.37 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 124300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 16430.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 86.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.5 | pg | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 372300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 63.13 | fL | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 1.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 10.0 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBCNUC | = | 0.0 | /100WBC | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1087330.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 45.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 41000.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 363.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 88.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 156.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 25000000.0 | nM | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 106.0 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 636.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 400.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 1.8 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1776.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 358.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 126.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 6.28 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 144.83 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 2.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 62000.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 22.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 66.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 9301.33 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 105.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1026.33 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 0.67 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5740000.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 35.87 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 135300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 10500.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 88.67 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.57 | pg | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 377300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 62.5 | fL | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 1.0 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 9.67 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBCNUC | = | 0.33 | /100WBC | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1255330.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 46.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 42300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 304.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 92.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 24330000.0 | nM | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 110.67 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 460.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 383.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 1.2 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1040.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 123.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 7.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 143.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 5.64 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 148.07 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 1.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 63000.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 16.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 219.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 13357.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 239.33 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1117.33 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOSLE | = | 1.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5830000.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 36.57 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 141300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 14930.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 89.67 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 24.23 | pg | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 386700.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 62.73 | fL | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONOLE | = | 1.67 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 7.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1424000.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALT | = | 49.67 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALB | = | 40700.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ALP | = | 305.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | AST | = | 80.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BUN | = | 136.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CO2 | = | 26330000.0 | nM | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHLORIDE | = | 105.0 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CHOL | = | 523.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CK | = | 250.33 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | CREAT | = | 1.9 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | GLUC | = | 1726.7 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LDH | = | 79.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LIPASE | = | 8.0 | U.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PHOS | = | 125.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | POTASSIUM | = | 6.34 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | SODIUM | = | 144.67 | mEq.L-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | BILI | = | 1.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PROT | = | 60300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | URATE | = | 16.3 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | EOS | = | 118.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYM | = | 15030.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MONO | = | 170.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTSG | = | 1746.67 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | RBC | = | 5720000.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HCT | = | 35.6 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | HGB | = | 134300.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | WBC | = | 17070.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LYMLE | = | 88.0 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCH | = | 23.53 | pg | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCHC | = | 377700.0 | ug.mL-1 | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MCV | = | 62.37 | fL | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | NEUTLE | = | 10.33 | % | DOI[10.6019/CHEMBL3885881] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | PLAT | = | 1344670.0 | cells.uL-1 | DOI[10.6019/CHEMBL3885881] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|---|---|---|---|---|---|
| Homo sapiens | Liver | CL | = | 19.5 | mL.min-1.kg-1 | PMID[18768239] |
| Cavia porcellus | Ileum | Ke | = | 1.22 | nM | PMID[7205890] |
| Homo sapiens | Plasma | Fu | = | 0.57 | n.a. | PMID[22275465] |
| Homo sapiens | Liver | Fu | = | 1.0 | n.a. | PMID[22275465] |
| Homo sapiens | Liver | Fu | = | 0.96 | n.a. | PMID[22275465] |
| Homo sapiens | Liver | CL | = | 10.0 | mL.min-1.g-1 | PMID[22275465] |
| Homo sapiens | Liver | CL | = | 55.6 | mL.min-1.g-1 | PMID[22275465] |
| Homo sapiens | Liver | Drug metabolism | = | 0.65 | ml/min.kg | PMID[22275465] |
| Homo sapiens | Liver | Drug metabolism | = | 0.89 | ml/min.kg | PMID[22275465] |
| Homo sapiens | Liver | CL | = | 14.1 | mL.min-1.kg-1 | PMID[22275465] |
| Homo sapiens | Liver | CL | = | 19.3 | mL.min-1.kg-1 | PMID[22275465] |
| Homo sapiens | Intestine | Fu | = | 1.0 | n.a. | PMID[22275465] |
| Homo sapiens | n.a. | Fu | = | 0.54 | n.a. | PMID[18426954] |
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC201055 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC201055 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Drug ID | Developmental Stage |
|---|---|---|---|
| 1.0 | High Similarity | NPD3452 | Phase 4 |
| 0.9836 | High Similarity | NPD3450 | Approved |
| 0.8358 | Intermediate Similarity | NPD4004 | Phase 4 |
| 0.8235 | Intermediate Similarity | NPD4002 | Approved |
| 0.8154 | Intermediate Similarity | NPD2494 | Phase 4 |
| 0.803 | Intermediate Similarity | NPD2493 | Approved |
| 0.641 | Remote Similarity | NPD7907 | Phase 4 |
| 0.6316 | Remote Similarity | NPD4578 | Phase 4 |
| 0.6234 | Remote Similarity | NPD4577 | Approved |
| 0.6024 | Remote Similarity | NPD7906 | Approved |
| 0.5974 | Remote Similarity | NPD4111 | Phase 1 |
| 0.5897 | Remote Similarity | NPD4665 | Phase 4 |
| 0.5823 | Remote Similarity | NPD4663 | Approved |
| 0.5733 | Remote Similarity | NPD2975 | Phase 4 |
| 0.5714 | Remote Similarity | NPD6997 | Phase 2 |
| 0.5658 | Remote Similarity | NPD2974 | Approved |
| 0.5158 | Remote Similarity | NPD7048 | Phase 4 |
| 0.5104 | Remote Similarity | NPD7047 | Phase 3 |
| 0.5062 | Remote Similarity | NPD3448 | Phase 2 |
| 0.5062 | Remote Similarity | NPD4040 | Phase 1 |
| 0.5059 | Remote Similarity | NPD2973 | Approved |
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
